Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.
Cervical Cancer
Improved Overall Survival With Cemiplimab in Cervical Cancer Trial
The phase 3 trial evaluated the efficacy and safety of cemiplimab in women 18 years of age and older with recurrent or metastatic cervical cancer, including those with either squamous cell carcinoma or adenocarcinoma.
Delay in Cancer Treatment Linked to Increased Mortality
Association between delay and increased mortality significant for 13 of 17 indications.
Suspicion of Cervical Cancer May Increase Risk of Injury During Diagnostic Workup
Results of a large cohort study investigated sources of iatrogenic and noniatrogenic injuries in women coping with a potential diagnosis of cervical cancer.
Cervical Cancer Treatment Regimens
View a detailed drug treatment regimen chart for cervical cancer, including therapies such as cisplatin, cisplatin + 5-FU, and more.
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30.
American Cancer Society Updates Cervical Cancer Screening Guidelines
New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.
Pap/HPV Cotesting Better for Cervical Cancer Screening in Over 30s
Nondetection rate is 13.1 percent for cotesting, higher when testing is done >12 months prediagnosis.
American Cancer Society Updates HPV Vaccination Guidelines
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26.
Radiotherapy for Cervical Cancer: An Introduction to ASTRO’s Clinical Practice Guideline
The consensus guideline, drafted by an ASTRO-convened expert task force, offers recommendations about radiotherapy, including brachytherapy, and chemoradiation, in different stage-of-disease and treatment-strategy settings.
-
Loading...
-
Loading...
Next post in Cervical Cancer
